Evotec AG (EVTG.F) Q1 2013: Driving Innovation Efficiency
5/14/2013 9:36:43 AM
More...
|
Evotec AG (EVTG.F) to Report First Quarter Results on 14 May 2013
5/7/2013 9:39:41 AM
More...
|
Evotec AG (EVTG.F): New Hormone to Treat Diabetes Published in "Cell"
4/26/2013 11:06:09 AM
More...
|
Evotec AG (EVTG.F) and Yale University Form Open Innovation Alliance
1/9/2013 9:23:58 AM
More...
|
Evotec AG (EVTG.F) Expands Collaboration With MedImmune (AZN), Receives Milestone Payment
1/7/2013 9:35:51 AM
More...
|
Evotec AG (EVTG.F) Announces NMDA Antagonist License Agreement
12/17/2012 9:14:33 AM
More...
|
Evotec AG (EVTG.F), Janssen Pharmaceutical K.K. Sign License Agreement for Up to $175 Million
12/17/2012 7:26:16 AM
More...
|
Evotec AG (EVTG.F) Partners With Haplogen to Develop Drugs for Infectious Diseases
11/15/2012 7:43:25 AM
More...
|
Evotec AG (EVTG.F) Reports 8% Revenue Growth and a Positive Operating Result of EUR 2.9 m in the First Nine Months of 2012
11/8/2012 9:54:58 AM
More...
|
Evotec AG (EVTG.F) to Report Results for the First Nine Months of 2012 on 08 November 2012
11/1/2012 6:57:51 AM
More...
|
|